Pharmaceutical companies hold the world's most valuable data: R&D, clinical trials, intellectual property. Nation-states actively invest in stealing it.
of the largest organisations have adapted their cyber strategy due to geopolitical volatility; pharma is a primary target for state actors
Cybersecurity in pharma and life sciences is about protecting R&D data, clinical trials and intellectual property, some of the most valuable data in the world. Pharmaceutical companies fall under NIS2, implemented in the Netherlands through the Cyberbeveiligingswet (Cbw), and also need to comply with GxP requirements for validated systems, the EU Medical Device Regulation (EU MDR) and the GDPR. Nation-states actively invest in stealing pharmaceutical knowledge. The main threats are nation-state theft of R&D data, ransomware on GxP-validated systems, supply chain attacks on CROs and CMOs and insider threats targeting intellectual property. Pharma and life sciences companies therefore mainly hire privacy officers with a pharmaceutical background, data security and DLP specialists, GRC consultants who know GxP, EU MDR and the GDPR and CISOs with life sciences experience.
Nation-state theft of R&D data
Ransomware on GxP-validated systems
Supply chain attacks on CROs and CMOs
Insider threats targeting intellectual property
Privacy Officers with pharmaceutical background
Data Security & DLP specialists
GRC consultants (GxP, EU MDR, GDPR)
CISOs with life sciences experience
48u
Average time-to-shortlist
97%
Clients return
7.000+
Professionals in network
100%
Cybersecurity focus
Pharmaceutical companies fall under NIS2, implemented in the Netherlands through the Cyberbeveiligingswet (Cbw), which has applied since 15 August 2026. GxP requirements for validated systems, the EU Medical Device Regulation (EU MDR) for medical devices and the GDPR for personal data, including clinical trial data, also apply. A security specialist in this sector needs to apply these frameworks together without disrupting system validation.
A pharmaceutical company mainly needs data security and DLP specialists to protect R&D data and intellectual property against theft by nation-states and insiders. Privacy officers with pharmaceutical experience, GRC consultants who know GxP, EU MDR and the GDPR and a CISO with life sciences experience are also important. Because CROs and CMOs are targets, supplier risk also needs attention.
MVPeople Group responds to every request within 4 hours and delivers introduction CVs for interim roles within 24 hours, often with a first profile within 4 hours. Candidates come from a network of more than 7,000 pre-screened cybersecurity professionals, including privacy, GRC and data security specialists. MVPeople is NEN-4400-1 certified, WAADI registered, holds the SNA quality mark and works DBA-proof.
Interim fits defined projects, such as a NIS2 gap analysis, a DLP implementation or securing a new GxP system. Permanent hiring fits the structural protection of intellectual property and ongoing privacy management. Many pharmaceutical companies combine an interim specialist for the build phase with a permanent hire to embed it. Through MVPermanent you receive CVs within 72 hours, and hiring typically takes 2 to 4 weeks.
Last updated by Mathijs Visser, Co-founder and Lead Consultant MVPeople Group.
MVPeople Group places cybersecurity professionals across all NIS2 sectors.
We introduce the first qualified interim candidates within 24 hours. 100% cybersecurity. 100% focus.
Join a leading biotech organisation in Utrecht for a 7-month interim assignment. You'll lead the integration of acquired lab IT systems into corporate standards while maintaining GxP compliance.
Run and migrate a business-critical PKI platform for an international biotech organisation. Own certificate lifecycle, CA infrastructure, and orchestrations across Dutch and Danish sites.
